MCM
MBOT icon

MAI Capital Management’s Microbot Medical MBOT Stock Holding History

MAI Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.41K Buy
+1,000
New +$2.23K ﹤0.01% 3852
2025
Q2 		– Sell
-1
Closed -$2 – 4013
2025
Q1 		$2 Hold
1
– – ﹤0.01% 3429
2024
Q4 		$2 Buy
+1
New +$1 ﹤0.01% 3489

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

MAI Capital Management's MBOT Position: Q1 2026 in Review

MAI Capital Management opened a new position in Microbot Medical (MBOT) in Q1 2026: 1,000 shares worth $2.41K. The stake represents ﹤0.01% of the portfolio and ranks #3852 among its holdings. This is a return to the name: MAI Capital Management previously reported a position in MBOT as recently as Q1 2025.

MAI Capital Management first reported a position in MBOT in Q4 2024 and has held it in 3 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • MAI Capital Management held 1,000 shares of Microbot Medical worth $2.41K as of Q1 2026.
  • Microbot Medical was a new MAI Capital Management position in Q1 2026.
  • Microbot Medical made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #3852 holding.
  • MAI Capital Management first reported a position in Microbot Medical in Q4 2024 and has held it in 3 quarters since.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.